Typhoid Fever Treatment in Pregnancy
Typhoid fever during pregnancy is treated with systemic antibiotics to hasten recovery and reduce complications and death [1]. Empiric therapy should select pregnancy-appropriate agents while awaiting culture and antimicrobial susceptibility results [1].
Antibiotic Therapy Selection in Pregnancy
- Ampicillin is recommended for typhoid fever in pregnant women when susceptibility allows, due to safety in pregnancy [2].
- Ceftriaxone is recommended for pregnant women with severe disease or multidrug-resistant (MDR) disease [2].
- Carbapenems are used for complicated typhoid fever when empiric therapy is indicated and susceptibility is pending [1].
Empiric Therapy Framework
- Uncomplicated illness is treated empirically with azithromycin per CDC guidance for suspected enteric fever, while awaiting culture results [1].
- Complicated illness is treated empirically with a carbapenem per CDC guidance while awaiting culture results [1].
- Pregnancy-specific guidance indicates azithromycin is unsafe in pregnant or nursing women, and alternatives should be used for typhoid fever in pregnancy [2].
Key Evidence Supporting These Recommendations
- Antibiotic treatment for typhoid fever lowers the risk of complications and death compared with no treatment [1].
- CDC guidance reports that typhoid fever fatality is <1% with appropriate treatment, compared with >10% before widespread antibiotic use [1].
Monotherapy vs Combination Therapy
- Pregnancy guidance supports single-agent therapy using agents selected by severity and resistance pattern (ampicillin for routine cases, ceftriaxone for severe or MDR disease) [2].
- CDC notes case reports suggesting benefit of adding a second antibiotic in XDR cases that do not improve on carbapenem monotherapy [1].
Treatment Initiation Thresholds and Monitoring
- Blood culture is the mainstay of diagnosis and should be used to confirm infection and guide antimicrobial selection [1].
- If fever does not improve within 5 days of antibiotic initiation, treatment with alternative antibiotics and evaluation for persistent foci of infection (e.g., abscess or extraintestinal infection) should be considered [1].
Common Pitfalls to Avoid
- Fluoroquinolones should not be used for empiric treatment of typhoid/paratyphoid fever in CDC guidance due to high rates of resistance among U.S.-acquired strains [1].
- Chloramphenicol is contraindicated during pregnancy in typhoid fever management recommendations [2].
Target Outcomes of Therapy
- The goals of therapy are clinical recovery, prevention of relapse, and prevention of complications and death [1].
- Relapse can occur 1–3 weeks after recovery, and relapse requires further antibiotic treatment [1].